Feb 19 (Reuters) - Pixium Vision SA ALPIX.PA :
* REG-PIXIUM VISION ANNOUNCES ISSUE OF € 1.25 MILLION NEW
TRANCHE
FROM ESGO FINANCING AGREEMENT TO CONTINUE TO ACCELERATE ITS
CLINICAL PROGRAMS
* HAS ISSUED 875 WARRANTS GIVING ACCESS TO CONVERTIBLE NOTES
AS
AGREED WITH US-BASED, HEALTHCARE SPECIALIZED INVESTOR, EUROPEAN
SELECT GROWTH OPPORTUNITIES FUND (ESGO)
* ALSO ISSUED A TRANCHE OF EUR 1.25 MILLION NOMINAL VALUE
CORRESPONDING TO 125 BONDS FOLLOWING ITS REQUEST TO ESGO TO
EXERCISE 125 TRANCHE WARRANTS OUT OF 875 ISSUED.
* FINANCING CONTRACT WITH ESGO SPECIFIES A MAXIMUM NOMINAL
AMOUNT
OF EUR 10 MILLION, WITHOUT INTEREST OVER A PERIOD OF NO MORE
THAN 30 MONTHS ANNOUNCED ON NOVEMBER 6, 2019
* FIRST TRANCHE HAS ALREADY BEEN EXECUTED
* THESE 875 TRANCHE WARRANTS ANNOUNCED TODAY MAY LEAD TO A
MAXIMUM
NUMBER OF 875 BONDS FOR UP TO EUR 8,750,000 NOMINAL VALUE
* IN COMING WEEKS WE EXPECT TO ANNOUNCE CLINICAL RESULTS
WITH
SECOND-GENERATION PRIMA GLASSES AHEAD OF TRIALSTART EXPECTED BY
YEAR-END 2020
Source text for Eikon: ID:nGNE4J4qdn
Further company coverage: ALPIX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))